Year archive

Optimind Pharma Corp. — 2021 filings

All 25 regulatory filings released by Optimind Pharma Corp. (OMND) in 2021, sourced directly from the official regulator.

25 Filings

2021 Period

2021 filings (25)

Filing	Released	Lang
Other.pdf Regulatory Filings	2021-12-09	English
Management information circular - English.pdf Regulatory Filings	2021-12-09	English
Other.pdf Regulatory Filings	2021-12-09	English
Notice of meeting - English.pdf Regulatory Filings	2021-12-09	English
Form of proxy - English.pdf Regulatory Filings	2021-12-09	English
Material change report - English.pdf Regulatory Filings	2021-11-30	English
News release - English.pdf Regulatory Filings	2021-11-30	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2021-11-17	English
News release - English.pdf Regulatory Filings	2021-11-16	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-11-10	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-11-10	English
Interim MD&A - English.pdf Regulatory Filings	2021-11-10	English
Interim financial statements/report – English.pdf Regulatory Filings	2021-11-10	English
News release - English.pdf Regulatory Filings	2021-10-27	English
Material change report - English.pdf Regulatory Filings	2021-06-07	English
News release - English.pdf Regulatory Filings	2021-06-07	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-05-12	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-05-12	English
Interim MD&A - English.pdf Regulatory Filings	2021-05-12	English
Interim financial statements/report – English.pdf Regulatory Filings	2021-05-12	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2021-03-23	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2021-03-23	English
Annual MD&A - English.pdf Regulatory Filings	2021-03-23	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2021-03-23	English
Audited annual financial statements – English.pdf Regulatory Filings	2021-03-23	English